Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1998-3-24
|
pubmed:abstractText |
Annexin I is a phospholipid and actin binding protein which may play a role in signal transduction to the cytoskeleton. Previous work reported the differential expression of annexin I mRNA among rat adenocarcinoma cell lines of various metastatic potential (MTLn3, MTLn2, MTC.4: highest to lowest, respectively) (Pencil et al. 1993, Breast Cancer Res Treat, 25, 165-74). This relationship has been extended to the protein level in in vitro cultures using Western blotting and flow cytometry. Annexin I protein levels in MTLn3 cells are 3- to 5-fold higher than in MTC.4 cells. The weakly metastatic cell line MTLn2 shows levels 1.5- to 2.5-fold higher than MTC.4. In vivo tumors were produced by injecting 1 x 10(6) cells into mammary fat pads of syngeneic rats and necropsies were performed 40 days later. Semiquantitative immunohistochemical color image analysis was performed using a polyclonal rat annexin I specific antibody. Annexin I protein expression was highest in lung metastases of MTLn3, at 8-fold the levels observed in the MTC.4 primary tumors. MTLn3 cells in the primary tumor had an annexin I specific optical density 3-fold higher than that of cells in the MTC.4 primary tumor. MTLn2 primary tumors had an annexin I specific optical density 1.5-fold higher than MTC.4. A proportion of human mammary adenocarcinomas also have positive annexin I immunoreactivity, often with more uniform annexin I staining in the lymph node metastases. These results suggest that there may be survival advantages for nascent metastatic cells with high annexin I levels.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0262-0898
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
113-21
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9514092-Adenocarcinoma,
pubmed-meshheading:9514092-Animals,
pubmed-meshheading:9514092-Annexin A1,
pubmed-meshheading:9514092-Breast Neoplasms,
pubmed-meshheading:9514092-Carcinoma, Ductal, Breast,
pubmed-meshheading:9514092-Humans,
pubmed-meshheading:9514092-Immunohistochemistry,
pubmed-meshheading:9514092-Lymphatic Metastasis,
pubmed-meshheading:9514092-Mammary Neoplasms, Experimental,
pubmed-meshheading:9514092-Neoplasm Metastasis,
pubmed-meshheading:9514092-RNA, Messenger,
pubmed-meshheading:9514092-Rats,
pubmed-meshheading:9514092-Rats, Inbred F344,
pubmed-meshheading:9514092-Tumor Cells, Cultured
|
pubmed:year |
1998
|
pubmed:articleTitle |
Elevated levels of annexin I protein in vitro and in vivo in rat and human mammary adenocarcinoma.
|
pubmed:affiliation |
Department of Pathology, University of Texas Medical Branch, Galveston 77555-0747, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|